Potent β-Lactam Inhibitors of Human Cytomegalovirus Protease

Christiane Yoakim, WW Ogilvie, Catherine Chabot, Chantal Grand‐Maître, Ingrid Guse, Bruno Haché, Stephen H. Kawai, Julie Naud, J O'Meara, Raymond Plante,

Antiviral chemistry & chemotherapy · 1998 · 35 citations · 24 references

Concepts

Abstract

A series of novel monobactam inhibitors of human cytomegalovirus (HCMV) protease has been described that possess a heterocyclic thiomethyl side chain at C-4. Changes to the heterocycle did not significantly change the inhibitory activity of these compounds in an enzymatic assay, although improvements in solubility and cell culture activity were noted. A number of permutations between C-4 substitutions and N-1 derivatives led to the identification of several beta-lactams with antiviral activity in a plaque reduction assay. N-methyl thiotetrazole-containing compounds were found to be the most potent inhibitors in the enzymatic assay.

References

24